ArticleCancer biotherapy & radiopharmaceuticals2019

Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.

Abigail E Besemer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.